Systemic gene transfer enables optogenetic pacing of mouse hearts
- 12 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 106 (2) , 338-343
Abstract
Aims Optogenetic pacing of the heart has been demonstrated in transgenic animals expressing Channelrhodopsin–2 (ChR2). However for the clinical use of optogenetics to treat cardiac arrhythmias, gene transfer to non–transgenic hearts is required. The aim of this study was to describe a reliable method for gene transfer of ChR2 into a sufficient percentage of cardiomyocytes to overcome the electrical sink of all the coupled non–expressing cardiomyocytes during optical pacing of the whole heart in vivo . Methods and Results Adeno–associated virus with cardiac tropism for expression of ChR2 in fusion to mCherry was systemically injected into wild type mouse hearts. Bright mCherry fluorescence was detected in the whole heart 4–10 weeks later. Single cell dissociation revealed that on average 58% cardiomyocytes were mCherry positive. These showed light–induced inward currents, action potentials and contractions. Pulsed illumination of the left ventricle induced ventricular pacing in vivo in 74% of mice and higher light intensities were required for reduced pulse duration or size of illumination. Non–responding hearts showed low AAV expression and the threshold for optical pacing was estimated to be 35–40% ChR2 expressing cardiomyocytes. Optical pacing in vivo was stable over extended periods without negative effects on normal sinus rhythm and ECG parameters after termination of stimulation indicating sufficient cardiac output during pacing. Conclusions Gene transfer generates sufficient ChR2 photocurrent for reliable optogenetic pacing in vivo and lays out the basis for future optogenetic pacemaker and pain–free defibrillation therapies.Keywords
This publication has 20 references indexed in Scilit:
- A comprehensive multiscale framework for simulating optogenetics in the heartNature Communications, 2013
- Immune responses to AAV vectors: overcoming barriers to successful gene therapyBlood, 2013
- Stimulating Cardiac Muscle by LightCirculation: Arrhythmia and Electrophysiology, 2011
- Optogenetic Control of Cardiac FunctionScience, 2010
- Optogenetic control of heart muscle in vitro and in vivoNature Methods, 2010
- So Little Source, So Much Sink: Requirements for Afterdepolarizations to Propagate in TissueBiophysical Journal, 2010
- Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure EventsNew England Journal of Medicine, 2009
- Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In VivoCirculation Research, 2006
- Millisecond-timescale, genetically targeted optical control of neural activityNature Neuroscience, 2005
- Channelrhodopsin-2, a directly light-gated cation-selective membrane channelProceedings of the National Academy of Sciences, 2003